Updated: 12/15/2019

Benign Prostatic Hyperplasia (BPH)

0%
Topic
Review Topic
0
0
N/A
N/A
Questions
3 3
0
0
0%
0%
Evidence
4 4
0
0
Overview
 

 
Snapshot
  • A 70-year-old man presents to his physician with difficulty initiating a stream and post-void dribbling. He also reports having increased urinary urgency and a weak urinary stream. Medical history is significant for hypertension and is not on medication. On digital rectal exam, his prostate is enlarged, non-tender, firm, and smooth. Urinalysis is unremarkable and prostate-specific antigen is elevated. He is started on tamsulosin to improve his lower urinary tract symptoms.
Introduction
  • Clinical definition
    • benign hyperplasia of the stromal and epithelial cells of the prostate that results in lower urinary tract symptoms (LUTS) such as
      • post-void dribbling
      • increased urinary frequency and urgency
      • nocturia
      • weak urinary stream
  • Epidemiology
    • demographics
      • men > 45 years of age
  • Pathogenesis
    • unclear; however, chronic inflammation and hormonal and vascular mechanisms may play a role
  • Associated conditions
    • obesity and metabolic syndromes
    • hypertension
    • type 2 diabetes mellitus
  • Prognosis
    • symptoms slowly and progressively worsen
Presentation
  • Symptoms
    • issues with urinary storage
      • e.g., nocturia, increased urinary frequency, urinary incontinence, and urgency
    • issues with voiding
      • e.g., weak urinary stream, hesistancy, straining to void, and post-void dribbling 
      • exacerbated by alpha-1 agonists 
    • irritative issues
      • e.g., urgency and increased urinary frequency 
  • Physical exam
    • digital rectal exam
      • a non-tender, smooth, elastic, and firm enlarged prostate
Studies
  • Labs
    • urinalysis
      • to detect the presence of a urinary tract infection or blood
    • prostate-specific antigen
      • non-specific
  • Diagnostic criteria
    • this is a clinical diagnosis based on history (e.g., storage, voiding, and/or irritating urinary symptoms) and physical exam (e.g., a non-tender, smooth, elastic, and firm enlarged prostate)
Differential
  • Prostate cancer
  • Prostatitis
  • Urinary tract infection
  • Bladder cancer
Treatment
  • Medical
    • α1-blockers (e.g., terazosin and tamsulosin)
      • indication
        • considered initial therapy in patients with LUTS secondary to BPH
          • results in immediate relief
          • caution in patients on a phosphodiesterase-5 inhibitor as this can cause severe hypotension
    • 5-α reductase inhibitors (e.g., finasteride)  
      • indication
        • can be used as alternative treatment in patients with LUTS secondary to BPH who cannot tolerate α1-blockers
          • takes time (6-12 months) for symptom improvement to be appreciated
    • phosphodiesterase-5 inhibitors (e.g., sildenafil)
      • indication
        • a reasonable treatment option in patients with LUTS secondary to BPH who have erectile dysfunction
  • Surgical
    • transurethral resection of the prostate
      • indication
        • a treatment option in patients who are unresponsive to medical treatment
        • in patients with recurrent UTIs, bladder stones, or gross hematuria secondary to their BPH
      • complication
        • retrograde ejaculation
        • erectile dysfunction
          • this is uncommon
Complications
  • UTI
  • Nephrolithiasis
  • Bladder stones
  • Chronic kidney disease
  • Hydronephrosis

 

 

Please rate topic.

Average 4.7 of 3 Ratings

Questions (3)
Question locked
Sorry, this question is for
PEAK Premium Subscribers only
Upgrade to PEAK
Question locked
Sorry, this question is for
PEAK Premium Subscribers only
Upgrade to PEAK

(M2.RL.17.4684) A 73-year-old man presents to his primary care physician complaining of increased urinary frequency, nocturia, and incomplete emptying after void. He is otherwise healthy, with no active medical problems. On examination, a large, symmetric, firm, smooth prostate is palpated, but otherwise the exam is normal. Which of the following is a potential complication of the patient's present condition? Tested Concept

QID: 107344
1

Prostate cancer

8%

(1/13)

2

Hydronephrosis

77%

(10/13)

3

Bladder cancer

0%

(0/13)

4

Prostatitis

15%

(2/13)

5

Renal cancer

0%

(0/13)

M 8 D

Select Answer to see Preferred Response

Evidence (4)
Topic COMMENTS (8)
Private Note